Omega Healthcare (OHI) Form 144 — 2,500 common shares to sell Aug 8, 2025

Rhea-AI Filing Summary

Omega Healthcare Investors Inc. (OHI) submitted a Form 144 notifying the proposed sale of 2,500 common shares through Fidelity Brokerage, with an aggregate market value of $100,900 and an approximate sale date of 08/08/2025. The filing identifies 295,000 as the number of shares outstanding in the report, which frames the proposed sale size.

The filer shows the shares were received as stock awards: 2,035 shares acquired on 06/03/2022 and 465 shares acquired on 06/10/2024, both recorded as compensation. The notice reports "Nothing to Report" for sales during the past three months and includes the standard signer representation that no undisclosed material adverse information exists.

Positive

• Clear, complete disclosure of transaction details: broker, share count, aggregate value, and sale date
• Source of shares disclosed (stock awards with acquisition dates) and "Nothing to Report" for prior three months, indicating no recent insider sales

Negative

• Insider proposes to sell shares (2,500 shares), which could be noted by investors even though size is modest
• Proposed sale equals ~0.85% of the reported 295,000 shares outstanding (based on figures in the filing)

Insights

Financial Analyst

TL;DR: Small, disclosed insider sale — 2,500 shares worth $100,900 scheduled for Aug 8, 2025, representing under 1% of reported outstanding shares.

The filing is a routine Form 144 reporting a proposed sale of 2,500 common shares at an aggregate value of $100,900. Using the reported 295,000 shares outstanding, the sale equals approximately 0.85% of that figure. The shares were granted as stock awards in 2022 and 2024 and classified as compensation, indicating this is a disposition of previously awarded equity rather than newly issued stock. No sales were reported in the prior three months. Overall, this disclosure is informational and unlikely to be material to valuation absent other undisclosed factors.

Corporate Governance Expert

TL;DR: Filing shows transparent disclosure and includes the signer’s representation about material nonpublic information and trading-plan language.

The Form 144 provides the broker name (Fidelity Brokerage Services LLC) and precise acquisition dates and amounts for the shares being sold, satisfying standard transparency expectations for insider dispositions. The notice also contains the customary declaration that the filer does not possess undisclosed material adverse information and references trading-plan representations. There are no reported sales in the past three months, and the transaction sizes are modest relative to the reported outstanding shares. From a governance perspective, the filing appears complete and procedural.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	FIDELITY BROKERAGE SERVICES LLC 245 Summer Street BOSTON MA 02110	2500	100900.00	295000	08/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/03/2022	Stock Award	ISSUER			2035	06/03/2022	Compensation
Common	06/10/2024	Stock Award	ISSUER			465	06/10/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the OHI Form 144 disclose?

The filing notifies a proposed sale of 2,500 common shares via Fidelity Brokerage with an aggregate value of $100,900 and an approximate sale date of 08/08/2025.

How many shares did the filer acquire and when?

The filer acquired 2,035 shares on 06/03/2022 and 465 shares on 06/10/2024, both listed as stock awards and recorded as compensation.

Who is handling the sale for OHI Form 144?

The broker listed is FIDELITY BROKERAGE SERVICES LLC, 245 Summer Street, Boston MA 02110.

Were there any insider sales in the past three months?

The filing reports "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

What assurance does the filer provide about undisclosed information?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed and references trading-plan representation language.